الفهرس 
Comparison of sublingual misoprostol and oxytocin infusion in control of blood loss associated with cesarean section
ContentsOnly 14 pages are availabe for public view
 |  | from | 196 |  |  |
| | | from | 196 | | |
Abstract
Postpartum hemorrhage (PPH) remains the main cause of direct maternal death worldwide. Uterine atony accounts for the majority of cases presenting with excessive bleeding during or following childbirth. The administration of uterotonic drugs during cesarean section (CS) and in the third stage of labor in vaginal delivery has an essential role to minimize the risk of PPH and to improve the maternal outcome. Oxytocin is considered to be a safe drug. Administration of misoprostol sublingually has been found to be effective in control of blood loss and preventing PPH after CS